Clinical Research Studies

If you have been diagnosed with breast cancer, you may qualify for a clinical trial studying prone (lying face down) accelerated breast and nodal intensity-modulated radiation therapy (IMRT). The goal of this Phase I/II trial is to evaluate feasibility and acute toxicity of prone IMRT to breast, axillary, and supraclavicular nodes. The study aims to improve the measurement of the absorbed dose delivered by ionizing radiation after initial prone set-up, evaluate changes in quality of life of patients assessed at baseline and after treatment, estimate incidence of late radiation toxicity, and examine genetic determinants of breast fibrosis.